Radioimmunotherapy in solid tumors
10.3760/cma.j.issn.2095-2848.2018.02.015
- VernacularTitle:实体瘤放射免疫治疗
- Author:
Dinghu WENG
1
;
Saimei QIN
;
Rui AN
Author Information
1. 华中科技大学同济医学院附属协和医院核医学科、湖北省分子影像重点实验室
- Keywords:
Radioimmunotherapy;
Solid tumors;
Trends
- From:
Chinese Journal of Nuclear Medicine and Molecular Imaging
2018;38(2):134-137
- CountryChina
- Language:Chinese
-
Abstract:
Radioimmunotherapy (RIT) is often used as an adjuvant therapy or consolidation therapy for cancer due to its relative high specificity and minimized radiation damage to non-targeted organs.The progress of RIT in solid tumors was slow,however,it has been developed quickly recently especially in elimination of residual micro-tumor lesions due to the application of α radionuclide,the progress in antibody preparation,and the implementation of new therapeutic strategies.
